{
    "organizations": [],
    "uuid": "437b1ad9ef79aeee09ba837b9380ac9d1a29d3d7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sorrento-says-its-car-t-cell-thera/brief-sorrento-says-its-car-t-cell-therapy-showed-therapeutic-activity-in-stage-iv-pancreas-cancer-in-early-stage-trial-idUSASB0C8R7",
    "ord_in_thread": 0,
    "title": "BRIEF-Sorrento Says Its CAR-T Cell Therapy Showed Therapeutic Activity In Stage IV Pancreas Cancer In Early Stage Trial",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 5 (Reuters) - Sorrento Therapeutics Inc:\n* SORRENTO THERAPEUTICS AUTOLOGOUS ANTI-CEA CAR-T CELL THERAPY FOR LIVER METASTASES DEMONSTRATES THERAPEUTIC ACTIVITY IN STAGE IV PANCREAS CANCER IN A PHASE 1B HITM-SURE TRIAL (NCT02850536) Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-05T21:21:00.000+02:00",
    "crawled": "2018-03-06T22:36:37.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "sorrento",
        "therapeutic",
        "inc",
        "sorrento",
        "therapeutic",
        "autologous",
        "cell",
        "therapy",
        "liver",
        "metastasis",
        "demonstrates",
        "therapeutic",
        "activity",
        "stage",
        "iv",
        "pancreas",
        "cancer",
        "phase",
        "1b",
        "trial",
        "nct02850536",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}